Show simple item record

dc.contributor.authorBlagden, Nicholas*
dc.contributor.authorBerry, David J.*
dc.contributor.authorParkin, A.*
dc.contributor.authorJaved, Hafsa S.*
dc.contributor.authorIbrahim, Asim*
dc.contributor.authorGavan, Pauline T.*
dc.contributor.authorDe Matos, Luciana L.*
dc.contributor.authorSeaton, Colin C.*
dc.date.accessioned2011-03-23T15:50:39Z
dc.date.available2011-03-23T15:50:39Z
dc.date.issued2008
dc.identifier.citationBlagden N, Berry DJ, Parkin A et al (2008) Current directions in co-crystal growth. New journal of chemistry. 32(10): 1659-1672.en_US
dc.identifier.urihttp://hdl.handle.net/10454/4848
dc.descriptionnoen_US
dc.description.abstractIn this feature article we will focus on the issues relating to the crystal growth of co-crystals, with a particular emphasis on drug development. The initial focus of this perspective is on the relevant literature examples that may be able to inform our understanding with regards co-crystal crystallisation and the allied supramolecular concepts. The second part of this perspective contains selected examples from our own work, which add to the literature perspective. Topics include; nucleation templates, in situ synchrotron XRD studies, solid-state synthesis through mixing and screening strategies.en_US
dc.language.isoenen_US
dc.subjectCrystal engineeringen_US
dc.subjectCrystal growthen_US
dc.subjectCo-crystalsen_US
dc.subjectDrug developmenten_US
dc.subjectCrystallisationen_US
dc.titleCurrent directions in co-crystal growth.en_US
dc.status.refereedYesen_US
dc.typeArticleen_US
dc.type.versionNo full-text in the repository
dc.identifier.doihttps://doi.org/10.1039/B803866J


This item appears in the following Collection(s)

Show simple item record